Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company is engaged in produce pharmaceutical product and they are well known and respected for Innovative and high quality pharmaceutical product.
Gufic Biosciences Limited, is a listed public company incorporated on 23 July, 1984. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 85.75 cr and the total paid-up capital is INR 10.03 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
16.8%
8.33%
8.07%
53.12%
1.81%
26.87%
-0.28
-1.42
-0.85
-6.75
-3.69
-0.3
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(32)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 130.0 cr
Saraswat Co-operative Bank Limited
No. of Loans: 5
Total Amount : 111.9 cr
Saraswat Co-operative Bank Ltd
No. of Loans: 1
Total Amount : 100.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 55.0 cr
Axis Bank Limited
No. of Loans: 2
Total Amount : 50.8 cr
Saraswat Co-op Bank Ltd
No. of Loans: 1
Total Amount : 40.0 cr
Saraswat Co-Operative Bank Limited
No. of Loans: 1
Total Amount : 17.3 cr
The Sarawat Co-operative Bank Limited
No. of Loans: 5
Total Amount : 6.2 cr
THE MEMON CO-OP.; BANK LTD.
No. of Loans: 1
Total Amount : 0.2 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Jayesh Pannalal Choksi
Shareholder
|
00001729 | 25 years |
| CEO | Pranav Jayesh Choksi
Shareholder
|
<HIDDEN> | 10 years |
| Whole-time Director | Pranav Jayesh Choksi
Shareholder
|
00001731 | 10 years |
| Whole-time Director | Pankaj Jayakumar Gandhi | 00001858 | 11 years |
| Director | Kamal Kishore Seth | 00194986 | 0 years |
| Director | Anu Sanjiv Aurora | 05120192 | 5 years |
| Director | Gopal Madhavbhai Daptari | 07660662 | 8 years |
| CFO | Devki Nandan Banwarilal Roonghta | <HIDDEN> | 6 years |
| CS | Ami Shah | <HIDDEN> | 9 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| GUFIC PRIVATE LIMITED |
Active
|
1.2 Cr | 3 | Gujarat |
| JAL PRIVATE LIMITED |
Active
|
2.1 L | 3 | Gujarat |
| GUFIC CHEM PRIVATE LIMITED |
Active
|
3.0 L | 3 | Karnataka |
| ZIRCON TECONICA PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| TRICON ENTERPRISES PRIVATE LIMITED |
Active
|
3.0 L | 1 | Maharashtra |
| GUFIC STRIDDEN BIO-PHARMA PRIVATE LIMITED |
Amalgamated
|
2.0 L | 2 | Maharashtra |
| MOTIF HOTELS PRIVATE LIMITED |
Converted to LLP
|
1.0 L | 2 | Maharashtra |
| ZIRE REALTY LIMITED |
Active
|
5.8 Cr | 1 | Maharashtra |
| MOTIF HOTELS LLP |
Active
|
1.0 L | 2 | Maharashtra |
| GUFIC LIFESCIENCES PRIVATE LIMITED |
Amalgamated
|
75.7 Cr | 2 | Gujarat |
| FC KINGSMEN LLP |
Active
|
10.5 L | 1 | Maharashtra |
| PLACER MERCANTILE AND INVESTMENTS PVT LT D |
Amalgamated
|
4.0 L | 1 | Gujarat |
| ZIRE TRADING PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| INDO-VIETNAMESE CHAMBER OF COMMERCE AND INDUSTRY |
Active
|
0.0 | 1 | Maharashtra |
| IPCA LABORATORIES LIMITED |
Active
|
25.4 Cr | 1 | Maharashtra |
The incorporation date of GUFIC BIOSCIENCES LIMITED is 23 July, 1984
The authorized share capital of GUFIC BIOSCIENCES LIMITED is INR ₹ 85.8 Cr.
The paid-up capital of GUFIC BIOSCIENCES LIMITED is INR ₹ 10.0 Cr.
The registered address of GUFIC BIOSCIENCES LIMITED is Shop - 37, First Floor, Kamala Bhavan II, S Nityanand Road , Andheri East, NA Mumbai Mumbai City Maharashtra - 400069
The CIN number of GUFIC BIOSCIENCES LIMITED is L24100MH1984PLC033519.
Expand
Delete
Collapse
See
details
